Login
$AMGN
$462.52 +$0.20 (0.04%) After hours

$AMGN 8-K SEC Filings

Filed On Filing
03 Nov 2026 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

27 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

THOUSAND OAKS, Calif. (Oct. 26, 2026) – Amgen (NASDAQ:AMGN) today announced the appointment of David W. Gibbs to its Board of Directors, effective immediately. Gibbs will serve on the Board’s Audit Committee and Compensation and Manageme...

04 Aug 2026 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

31 Jul 2026 8-K: Material Cybersecurity Incidents

In July 2026, Amgen Inc. (the "Company") identified unauthorized activity involving data stored in cloud environments hosted by third-party cloud service providers. Upon detecting the activity, the Company activated its cybersecurity res...

20 May 2026 8-K: Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting on May 19, 2026. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

19 May 2026 8-K: Departure/Election of Directors or Officers; Compensation

(The Company and the Employee are also each referred to as Party or jointly as Parties)

30 Apr 2026 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

22 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

THOUSAND OAKS, Calif. (April 22, 2026) – Amgen (NASDAQ:AMGN) today announced the retirement of David M. Reese, M.D., executive vice president and Chief Technology Officer, effective June 30, 2026.

19 Feb 2026 8-K: Entry into a Material Definitive Agreement

The undersigned officer of the Company certifies, pursuant to resolutions duly adopted by the Board of Directors at a meeting duly held on October 31, 2025 and by the Pricing Committee of the Board of Directors of the Company on February...

03 Feb 2026 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

30 Jan 2026 8-K: Termination of a Material Definitive Agreement

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

04 Nov 2025 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

05 Aug 2025 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

27 May 2025 8-K: Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting on May 23, 2025. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

01 May 2025 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

04 Feb 2025 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

30 Oct 2024 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

06 Aug 2024 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

03 Jun 2024 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

02 May 2024 8-K: Results of Operations and Financial Condition

One Amgen Center DriveThousand Oaks, CA 91320-1799Telephone 805-447-1000www.amgen.com

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support